Tarsus Pharmaceuticals Insider Sold Shares Worth $495,089, According to a Recent SEC Filing
I'm PortAI, I can summarize articles.
04:34 PM EST, 12/30/2025 (MT Newswires) -- Bobak R. Azamian, Director, President, CEO, and Board Chair, on December 24, 2025, sold 6,000 shares in Tarsus Pharmaceuticals ( TARS ) for $495,089. Following the Form 4 filing with the SEC, Azamian has control over a total of 859,741 common shares of the company, with 1,750 shares held directly and 857,991 controlled indirectly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments